189 related articles for article (PubMed ID: 37108521)
21. The genetically modified suilysin, rSLY(P353L), provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis.
Du H; Huang W; Xie H; Ye C; Jing H; Ren Z; Xu J
Vaccine; 2013 Aug; 31(38):4209-15. PubMed ID: 23856333
[TBL] [Abstract][Full Text] [Related]
22. Acacetin attenuates Streptococcus suis virulence by simultaneously targeting suilysin and inflammation.
Xie S; Zhang Y; Xu L; Li S; Shen X; Li L; Deng X; Zhou Y
Microb Pathog; 2022 Jan; 162():105354. PubMed ID: 34896203
[TBL] [Abstract][Full Text] [Related]
23. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2.
Lun S; Perez-Casal J; Connor W; Willson PJ
Microb Pathog; 2003 Jan; 34(1):27-37. PubMed ID: 12620382
[TBL] [Abstract][Full Text] [Related]
24. Increased production of suilysin contributes to invasive infection of the Streptococcus suis strain 05ZYH33.
He Z; Pian Y; Ren Z; Bi L; Yuan Y; Zheng Y; Jiang Y; Wang F
Mol Med Rep; 2014 Dec; 10(6):2819-26. PubMed ID: 25241621
[TBL] [Abstract][Full Text] [Related]
25. [Study on the molecular epidemiology of Streptococcus suis type 2 from healthy pigs in Guangxi].
Xiong Y; Liu Q; Qin FY; Bai Y; Zhu W; Li HM; Guo JG; Qin L; Pan J; Long JM; Chen L
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jun; 28(6):593-6. PubMed ID: 17939392
[TBL] [Abstract][Full Text] [Related]
26. ARF6 promotes Streptococcus suis suilysin induced apoptosis in HBMECs.
Jiang C; Zhou P; Zhang X; Ma N; Hu Y; Zhang M; Ghonaim AH; Li H; Dong L; Zeng W; Li C; Lang Y; Sun Y; He Q; Li W
Int J Biol Macromol; 2024 May; 268(Pt 2):131839. PubMed ID: 38663699
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin.
Lu Y; Yang L; Zhang W; Xie S; Zhao F; Peng X; Qin Z; Zeng D; Zeng Z
Drug Deliv; 2022 Dec; 29(1):2824-2830. PubMed ID: 36062487
[TBL] [Abstract][Full Text] [Related]
28. Metabolomics and proteomics analyses revealed mechanistic insights on the antimicrobial activity of epigallocatechin gallate against
Gao T; Ye F; Tan Y; Peng M; Yuan F; Liu Z; Zhou D; Yang K; Liu W; Guo R; Zhang T; Zheng L; Zhou R; Tian Y
Front Cell Infect Microbiol; 2022; 12():973282. PubMed ID: 36204637
[No Abstract] [Full Text] [Related]
29. Effects of Suilysin on
Zhang S; Wang J; Chen S; Yin J; Pan Z; Liu K; Li L; Zheng Y; Yuan Y; Jiang Y
Front Cell Infect Microbiol; 2016; 6():128. PubMed ID: 27800304
[TBL] [Abstract][Full Text] [Related]
30. A novel intranasal mouse model for mucosal colonization by Streptococcus suis serotype 2.
Seitz M; Beineke A; Seele J; Fulde M; Valentin-Weigand P; Baums CG
J Med Microbiol; 2012 Sep; 61(Pt 9):1311-1318. PubMed ID: 22556325
[TBL] [Abstract][Full Text] [Related]
31. Canagliflozin Inhibited the Activity of Hemolysin and Reduced the Inflammatory Response Caused by
Li X; Li Q; Zhang Z; Wang C; Huo X; Lai H; Lu H; Lu W; Qian Y; Dong W; Tan C; Liu M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685881
[TBL] [Abstract][Full Text] [Related]
32. Polysaccharide capsule and suilysin contribute to extracellular survival of Streptococcus suis co-cultivated with primary porcine phagocytes.
Benga L; Fulde M; Neis C; Goethe R; Valentin-Weigand P
Vet Microbiol; 2008 Nov; 132(1-2):211-9. PubMed ID: 18565698
[TBL] [Abstract][Full Text] [Related]
33. Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.
Kock C; Beineke A; Seitz M; Ganter M; Waldmann KH; Valentin-Weigand P; Baums CG
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):135-45. PubMed ID: 19505730
[TBL] [Abstract][Full Text] [Related]
34. Role of capsule and suilysin in mucosal infection of complement-deficient mice with Streptococcus suis.
Seitz M; Beineke A; Singpiel A; Willenborg J; Dutow P; Goethe R; Valentin-Weigand P; Klos A; Baums CG
Infect Immun; 2014 Jun; 82(6):2460-71. PubMed ID: 24686060
[TBL] [Abstract][Full Text] [Related]
35. Identification of in-vivo induced genes of Streptococcus suis serotype 2 specially expressed in infected human.
Li S; Song J; Huang H; Chen W; Li M; Zhao Y; Cong Y; Zhu J; Rao X; Hu X; Hu F
Microb Pathog; 2013 Oct; 63():8-15. PubMed ID: 23747686
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of the gene encoding suilysin from Streptococcus suis and expression in field strains.
Segers RP; Kenter T; de Haan LA; Jacobs AA
FEMS Microbiol Lett; 1998 Oct; 167(2):255-61. PubMed ID: 9809426
[TBL] [Abstract][Full Text] [Related]
37.
Zhao F; Yang N; Wang X; Mao R; Hao Y; Li Z; Wang X; Teng D; Fan H; Wang J
Front Cell Infect Microbiol; 2019; 9():48. PubMed ID: 30863725
[TBL] [Abstract][Full Text] [Related]
38. Human infection caused by Streptococcus suis serotype 2 in China: report of two cases and epidemic distribution based on sequence type.
Jiang F; Guo J; Cheng C; Gu B
BMC Infect Dis; 2020 Mar; 20(1):223. PubMed ID: 32171281
[TBL] [Abstract][Full Text] [Related]
39. Fisetin Lowers
Zhang Y; Zong B; Wang X; Zhu Y; Hu L; Li P; Zhang A; Chen H; Liu M; Tan C
Front Microbiol; 2018; 9():1723. PubMed ID: 30105012
[No Abstract] [Full Text] [Related]
40. Autophagy is a defense mechanism controlling Streptococcus suis serotype 2 infection in murine microglia cells.
Yue C; Hu C; Xiang P; Zhang S; Xiao H; Zhou W; Jin H; Shi D; Li J; Xu L; Chen Y; Zeng Y
Vet Microbiol; 2021 Jul; 258():109103. PubMed ID: 33991788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
